product Image
DiaPlexQ™ PneumoPatho 13 Detection Kit (Others)
Model Name
-
Series
Molecular Diagnostic (Pathogen Detection)
Data
-
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125224
Product Name
DiaPlexQ™ PneumoPatho 13 Detection Kit (Others)
Model Name
-
Size
-
Weight
-
Product Details

DiaPlexQ™ PneumoPatho 13 Detection Kit

Real-Time PCR based assay system for simultaneous detection of pneumonia species

RUO


Pneumonia is usually caused by infection with viruses or bacteria, and less commonly by other microorganisms, certain drugs and other conditions such as autoimmune diseases. Pneumonia affects approximately 450 million people globally per year, seven percent of the global population, and results in about 4 million deaths per year, mostly in third world countries.





Specification





Detection target
Set I : M. pneumoniae (MP)
K. pneumoniae (KP)
L. pneumophila (LP)
Set III : P. aeruginosa (PA)
M. catarrhalis (MC)
B. pertussis (BP)
Set II : S. pneumoniae (SP)
S. aureus (SA)
C. pneumoniae (CP)
Set IV : H. influenzae (HI)
A. baumannii (AB)
M. tuberculosis/ M. avium (TB/AV)
RegistrationRUO
Detection technologyReal-Time PCR
Specimen typeNasopharyngeal swab, Nasopharyngeal aspirate, onchoalveolar lavage (BAL), Nasal swab, Oropharyngeal swab, Sputum
Analytical sensitivity10 - 10² copies
Compatible instruments*ABI 7500 / 7500 Fast Real-Time PCR System (Applied Biosystems)
CFX96™ Real-Time PCR System (Bio-Rad)
PCR running time~ 2 hrs




Features

- HotStart PCR system : Ultra high specific and sensitive result

- UDG system : No carryover contamination

- Multiplex PCR system : Multiple targets in a single reaction

- Reliable system : Automatic PCR control

- Positive control included

- Easy-to-use master mix






Experimental







Citation&Papers

Micheal J McConnell et al.

Quantitative Real-Time PCR for Detection of Acinetobacter baumannii Colonization in the Hospital Environment. Journal of Clinical Microbiology p. 1412-1414.

Ko WC, Paterson DL, Sagnimeni AJ,

et al. Community-acquired Klebsiella pneumonia bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002; 8:160-6.

Gierczynski R, Jagielski M, Rastswicki W, Klauzewski S (2007)

Multiplex-PCR assay for idenrification of Klebsiella pneumonia isolates carrying the chain loci for K1 and K2 capsule biosynthesis. Pol J Microbiol 56: 153-156.







Ordering information

TechnologyCat. No.ProductContents






Real-Time PCR
SQD81-K020
(20 reaction)






DiaPlexQ ™ PneumoPatho 13 Detection Kit
2X Multiplex Real-Time PCR Smart mix (with UDG) (PneumoPatho 13)
Primer & Probe Mixture I (PneumoPatho 13)
Primer & Probe Mixture II (PneumoPatho 13)
Primer & Probe Mixture III (PneumoPatho 13)
Primer & Probe Mixture IV (PneumoPatho 13)
Control Template I (PneumoPatho 13)
Control Template II (PneumoPatho 13)
Control Template III (PneumoPatho 13)
Control Template IV (PneumoPatho 13)
Nuclease free Water
SQD81-K100
(100 reaction)



More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry